Emergence of AI Healthcare Policy Amidst Fragme...

By João L. Carapinha

May 25, 2026

The rapid evolution of AI Healthcare Policy is evident in the Health & AI Policy Index (HAPI) snapshot from January 1, 2026, which catalogs 240 policies illustrating swift expans...
Hepcludex HDV Approval: A Breakthrough in Chronic Hepatitis Delta Treatment
Novartis Oncology Advancements: Key Trial Findings and Market Implications
Baxfendy Hypertension Treatment: FDA Approves First-in-Class Aldosterone Synt...
TrumpRx.gov Expansion: Enhancing Medication Price Transparency and Competition
PSA Response Improvement: Promising Data from Pluvicto in mHSPC Treatment
Enhertu Breast Cancer Treatment Gains FDA Approval in Neoadjuvant and Adjuvan...
Pharmaceutical Onshoring Agreements: Navigating Tariff Relief and National Se...
Dynamic Risk Stratification in Thromboembolism Prevention for Cancer Patients
Merck Oncology Advancements Highlight Long-Term Data and Pipeline Progress at...
Johnson & Johnson Advances Neuropsychiatry Treatment Innovations at APA ...
Breakthrough in Biocatalysis: Advancing Oral PCSK9 Inhibitors
FDA Endorses Truqap Prostate Cancer Therapy for PTEN-Deficient Cases